Rationale for the treatment of von Willebrand's disease.
D000941:Antigens / Q000627:therapeutic use*; D001760:Bleeding Time; D005169:Factor VIII / Q000276:immunology* / Q000627:therapeutic use*; D006801:Humans; D010973:Platelet Adhesiveness; D014842:von Willebrand Diseases / Q000097:blood / Q000628:therapy*; D014841:von Willebrand Factor
D000941:Antigens; D014841:von Willebrand Factor; D005169:Factor VIII